Design, synthesis, anticancer evaluation and docking studies of new pyrimidine derivatives as potent thymidylate synthase inhibitors

Bioorganic Chemistry
Lamia H T AminHend M A El-Sehrawi

Abstract

Cancer is a perplexing and challenging problem for researchers. In this study, a series of 6-aryl-5-cyano-pyrimidine derivatives were designed, synthesized and evaluated for their anticancer activity against HePG-2, MCF-7 and HCT-116 cell lines. Compounds 2, 3d, 4a-c, 5, 8 and 12 displayed high anticancer activity, comparable to that of 5-fluorouracil. Additionally, those compounds with effective anticancer activity were further assessed for their ability to inhibit thymidylate synthase (TS) enzyme. All the tested compounds demonstrated a marked TS inhibitory activity (33.66-74.98%), with IC50 ranging from 3.89 to 15.74 nM. Moreover, apoptosis studies were conducted on the most potent compound 8, to evaluate its proapoptotic potential. Interestingly, compound 8 induced the level of active caspase 3, and elevated the Bax/Bcl2 ratio 44 folds in comparison to the control. Finally, a molecular docking study was conducted to detect the probable interaction between the active compounds and the thymidylate synthase active site.

References

Jul 4, 1990·Journal of the National Cancer Institute·P SkehanM R Boyd
Jan 1, 1995·Acta Crystallographica. Section A, Foundations of Crystallography·R H Blessing
May 2, 2003·Nature Reviews. Cancer·Daniel B LongleyPatrick G Johnston
May 24, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H H J BackusG J Peters
Sep 24, 2005·Current Medicinal Chemistry·M P CostiD Barlocco
Sep 5, 2006·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Wataru Ichikawa
Jan 6, 2011·Acta Crystallographica. Section D, Biological Crystallography·Lydia M GibsonLukasz Lebioda
May 28, 2011·International Journal of Cancer. Journal International Du Cancer·Paolo CeppiGiorgio V Scagliotti
Sep 13, 2011·Expert Opinion on Investigational Drugs·Elena GalvaniElisa Giovannetti
Jan 1, 2011·African Journal of Traditional, Complementary, and Alternative Medicines : AJTCAM·Md Asaduzzaman KhanDian-zheng Zhang
Dec 5, 2013·Journal of Pharmacy & Bioallied Sciences·Chirag RamiJayshree P Parmar
Dec 23, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Laura TaddiaMaria Paola Costi
Jun 22, 2016·World Journal of Gastrointestinal Oncology·Kemal I DeenPramodh C Chandrasinghe

❮ Previous
Next ❯

Citations

May 2, 2020·Journal of Enzyme Inhibition and Medicinal Chemistry·Zohor Mohammad Mahdi AlzhraniSyed Nazreen
Jan 30, 2020·Current Topics in Medicinal Chemistry·Xiaoyue WenXinyue Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis